한글목차

소아천식 치료 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 116억 5,000만 달러에서 2026년에는 123억 1,000만 달러에 이르고, CAGR 5.7%로 성장할 전망입니다. 지난 몇 년간 성장 요인으로는 소아 전용 천식 치료제공급 제한, 병원 기반 치료 의존도, 소아 천식 유병률 증가, 보호자 인식 개선, 기존 흡입기 및 단시간 작용 베타자극제 보급 등을 꼽을 수 있습니다.

소아천식 치료 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 151억 4,000만 달러에 이르고, CAGR은 5.3%를 나타낼 전망입니다. 예측 기간 동안 성장 요인으로는 생물학적 제제 및 병용요법 개발, 디지털 건강 모니터링 기기의 통합, 재택치료 서비스 확대, 온라인 약국 이용 증가, 소아 천식 치료제에 대한 규제 당국의 승인 증가 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 개인 맞춤형 소아 천식 치료법 채택 확대, 생물학적 제제 및 복합 흡입기 사용 증가, 재택치료 및 원격 환자 모니터링의 성장, 온라인 및 소매 약국 유통 채널 확대, 조기 진단 및 예방적 천식 관리에 대한 관심 증가 등이 있습니다.

호흡기 감염증 증가 추세는 향후 몇 년 동안 소아 천식 치료제 시장의 성장을 가속할 것으로 예측됩니다. 호흡기 감염은 바이러스, 세균, 기타 병원균에 의해 발생하는 질병으로 코, 목, 기도, 폐를 포함한 호흡기에 영향을 미치는 질환입니다. 이러한 증가 추세는 주로 대기오염의 악화에 기인하며, 미립자 물질과 이산화질소 등의 오염물질에 노출되면 호흡기가 약화되어 감염에 대한 감수성이 높아지기 때문입니다. 소아 천식 치료는 기도 기능의 개선과 염증의 최소화를 통해 호흡기 감염의 발생 빈도와 중증도를 감소시키고, 감염 유발 요인에 대한 취약성을 감소시킵니다. 예를 들어, 2024년 6월 호주 보건 복지 연구소가 발표한 보고서에 따르면, 2023년 만성폐쇄성폐질환(COPD)은 전체 질병 부담의 3.6%를 차지했으며, 전체 호흡기 질환 부담의 50%를 차지했습니다. 따라서 호흡기 감염증 증가 추세는 소아 천식 치료제 시장의 성장을 가속하고 있습니다.

소아 천식 치료제 시장의 주요 기업들은 소아 천식 치료제 시장에서 단일클론항체와 같은 혁신적인 치료법에 집중하고 있으며, 소아의 기도 염증을 구체적으로 표적화하여 감소시키는 것을 목표로 하고 있습니다. 단일클론항체는 유해한 세포나 물질을 중화시키는 면역체계의 능력을 모방하여 실험실에서 설계한 단백질입니다. 예를 들어, 2024년 4월 영국에 본사를 둔 제약사 아스트라제네카(AstraZeneca)는 중증 호산구성 천식을 앓고 있는 6-11세 어린이를 위한 추가 유지 치료제로 FASENRA(벤라리주맙)의 미국 FDA 승인을 획득했습니다. FASENRA는 호산구를 표적으로 제거하여 천식 발작을 감소시키며, 최초 3회분은 4주마다, 이후 8주마다 피하주사로 투여합니다. 소아 용량은 체중에 따라 조정됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Pediatric asthma treatment refers to the medical management and therapeutic interventions aimed at controlling and alleviating asthma symptoms in children. It involves the use of medications, lifestyle adjustments, and monitoring strategies to reduce inflammation, prevent asthma attacks, and improve respiratory function.

The main types of pediatric asthma treatment include long-term control medications, quick-relief medications, and other therapies. Long-term control medications are taken daily over an extended period to reduce inflammation, prevent symptoms, and maintain stable lung function. This category includes inhaled corticosteroids, long-acting beta agonists, leukotriene modifiers, antihistamines, and biologics. These medications are administered through various routes, including oral, nasal, and injectable forms. They are distributed via hospital pharmacies, retail pharmacies, and online pharmacies, and are used across multiple settings, such as hospitals, clinics, homecare, and other healthcare environments.

Tariffs have affected the pediatric asthma treatment market by increasing the cost of imported active pharmaceutical ingredients (APIs) and specialized inhaler devices. Segments such as biologics, combination inhalers, and short-acting beta agonists are particularly impacted, with regions like North America and Asia-Pacific facing higher import duties. This has led to increased treatment costs and supply chain disruptions. Positively, tariffs are encouraging local production of pediatric asthma drugs, innovation in inhaler technologies, and investment in domestic pharmaceutical manufacturing capacities.

The pediatric asthma treatment market research report is one of a series of new reports from The Business Research Company that provides pediatric asthma treatment market statistics, including pediatric asthma treatment industry global market size, regional shares, competitors with a pediatric asthma treatment market share, detailed pediatric asthma treatment market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric asthma treatment industry. This pediatric asthma treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pediatric asthma treatment market size has grown strongly in recent years. It will grow from $11.65 billion in 2025 to $12.31 billion in 2026 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to limited availability of pediatric-specific asthma medications, reliance on hospital-based treatment, growing prevalence of childhood asthma, increasing awareness among caregivers, adoption of conventional inhalers and short-acting beta agonists.

The pediatric asthma treatment market size is expected to see strong growth in the next few years. It will grow to $15.14 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to development of biologics and combination therapies, integration of digital health monitoring devices, expansion of home care services, rising online pharmacy adoption, increasing regulatory approvals for pediatric asthma drugs. Major trends in the forecast period include increasing adoption of personalized pediatric asthma therapies, rising use of biologic treatments and combination inhalers, growth in home care and remote patient monitoring, expansion of online and retail pharmacy distribution channels, focus on early diagnosis and preventive asthma management.

The rising prevalence of respiratory infections is expected to drive growth in the pediatric asthma treatment market in the coming years. Respiratory infections are illnesses caused by viruses, bacteria, or other pathogens that affect the respiratory tract, including the nose, throat, airways, and lungs. Their increasing prevalence is largely attributed to rising air pollution, as exposure to pollutants like particulate matter and nitrogen dioxide weakens the respiratory system, making individuals more susceptible to infections. Pediatric asthma treatments help reduce the frequency and severity of respiratory infections by improving airway function and minimizing inflammation, which lowers vulnerability to infectious triggers. For instance, in June 2024, the Australian Institute of Health and Welfare reported that chronic obstructive pulmonary disease accounted for 3.6% of the total disease burden in 2023 and represented 50% of the overall burden of respiratory conditions. Therefore, the rising prevalence of respiratory infections is propelling growth in the pediatric asthma treatment market.

Key companies in the pediatric asthma treatment market are focusing on innovative therapies such as monoclonal antibodies to specifically target and reduce airway inflammation in children. Monoclonal antibodies are laboratory-engineered proteins that mimic the immune system's ability to neutralize harmful cells or substances. For example, in April 2024, AstraZeneca PLC, a UK-based pharmaceutical company, received U.S. FDA approval for FASENRA (benralizumab) as an add-on maintenance treatment for children aged 6-11 years with severe eosinophilic asthma. FASENRA reduces asthma exacerbations by targeting and eliminating eosinophils and is administered via subcutaneous injection every four weeks for the first three doses, then every eight weeks, with pediatric dosing adjusted by body weight.

In January 2025, Molex LLC, a US-based consumer electronics company, acquired Vectura Group plc for an undisclosed amount. Through this acquisition, Molex aims to expand its inhalation drug delivery capabilities and strengthen its position in providing end-to-end solutions for respiratory and non-respiratory therapies. Vectura Group Services Limited, based in the UK, is developing a pediatric asthma treatment, a smart budesonide delivery system known as VR647.

Major companies operating in the pediatric asthma treatment market are Pfizer Inc., Merck And Co Inc., Novartis AG, Sanofi S.A., AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Limited, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Genentech Inc., Chiesi Farmaceutici S.p.A, Dr. Reddy's Laboratories Ltd, Cipla Ltd, Lupin Limited, Zydus Lifesciences Ltd.

North America was the largest region in the pediatric asthma treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pediatric asthma treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pediatric asthma treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pediatric asthma treatment market consists of sales of nebulizers and soft-mist inhalers, oral medications, biologic injectables, and smart monitoring tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pediatric Asthma Treatment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pediatric asthma treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pediatric asthma treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pediatric asthma treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Long-Term Control Medications; Quick-Relief Medications; Other Types
• 2) By Drug Class: Inhaled Corticosteroids; Long-Acting Beta Agonists; Leukotriene Modifiers; Antihistamines; Biologics
• 3) By Route Of Administration: Oral Route; Nasal Route; Injectable Route
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 5) By End User: Hospitals; Clinics; Home Care; Other End users
• Subsegments:
• 1) By Long-Term Control Medications: Inhaled Corticosteroids; Leukotriene Modifiers; Long-Acting Beta Agonists; Combination Inhalers; Biologic Therapies
• 2) By Quick-Relief Medications: Short-Acting Beta Agonists; Anticholinergics; Systemic Corticosteroids
• 3) By Other Types: Immunotherapy; Methylxanthines; Alternative Therapies
• Companies Mentioned: Pfizer Inc.; Merck And Co Inc.; Novartis AG; Sanofi S.A.; AstraZeneca plc; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Amgen Inc.; Boehringer Ingelheim International GmbH; Viatris Inc.; Teva Pharmaceutical Industries Limited; Regeneron Pharmaceuticals Inc.; Sun Pharmaceutical Industries Limited; Genentech Inc.; Chiesi Farmaceutici S.p.A; Dr. Reddy's Laboratories Ltd; Cipla Ltd; Lupin Limited; Zydus Lifesciences Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Pediatric Asthma Treatment Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Pediatric Asthma Treatment Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Pediatric Asthma Treatment Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Pediatric Asthma Treatment Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.2 Biotechnology, Genomics & Precision Medicine
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Personalized Pediatric Asthma Therapies
  • 4.2.2 Rising Use Of Biologic Treatments And Combination Inhalers
  • 4.2.3 Growth In Home Care And Remote Patient Monitoring
  • 4.2.4 Expansion Of Online And Retail Pharmacy Distribution Channels
  • 4.2.5 Focus On Early Diagnosis And Preventive Asthma Management

5. Pediatric Asthma Treatment Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Clinics
• 5.3 Home Care Providers
• 5.4 Pharmacies
• 5.5 Pediatric Research Institutions

6. Pediatric Asthma Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pediatric Asthma Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Pediatric Asthma Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Pediatric Asthma Treatment Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Pediatric Asthma Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Pediatric Asthma Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pediatric Asthma Treatment Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pediatric Asthma Treatment Market Segmentation

• 9.1. Global Pediatric Asthma Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Long-Term Control Medications, Quick-Relief Medications, Other Types
• 9.2. Global Pediatric Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Inhaled Corticosteroids, Long-Acting Beta Agonists, Leukotriene Modifiers, Antihistamines, Biologics
• 9.3. Global Pediatric Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral Route, Nasal Route, Injectable Route
• 9.4. Global Pediatric Asthma Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
• 9.5. Global Pediatric Asthma Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Clinics, Home Care, Other End users
• 9.6. Global Pediatric Asthma Treatment Market, Sub-Segmentation Of Long-Term Control Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Inhaled Corticosteroids, Leukotriene Modifiers, Long-Acting Beta Agonists, Combination Inhalers, Biologic Therapies
• 9.7. Global Pediatric Asthma Treatment Market, Sub-Segmentation Of Quick-Relief Medications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Short-Acting Beta Agonists, Anticholinergics, Systemic Corticosteroids
• 9.8. Global Pediatric Asthma Treatment Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Immunotherapy, Methylxanthines, Alternative Therapies

10. Pediatric Asthma Treatment Market Regional And Country Analysis

• 10.1. Global Pediatric Asthma Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Pediatric Asthma Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pediatric Asthma Treatment Market

• 11.1. Asia-Pacific Pediatric Asthma Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Pediatric Asthma Treatment Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pediatric Asthma Treatment Market

• 12.1. China Pediatric Asthma Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Pediatric Asthma Treatment Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pediatric Asthma Treatment Market

• 13.1. India Pediatric Asthma Treatment Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pediatric Asthma Treatment Market

• 14.1. Japan Pediatric Asthma Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Pediatric Asthma Treatment Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pediatric Asthma Treatment Market

• 15.1. Australia Pediatric Asthma Treatment Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pediatric Asthma Treatment Market

• 16.1. Indonesia Pediatric Asthma Treatment Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pediatric Asthma Treatment Market

• 17.1. South Korea Pediatric Asthma Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Pediatric Asthma Treatment Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pediatric Asthma Treatment Market

• 18.1. Taiwan Pediatric Asthma Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Pediatric Asthma Treatment Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pediatric Asthma Treatment Market

• 19.1. South East Asia Pediatric Asthma Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Pediatric Asthma Treatment Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pediatric Asthma Treatment Market

• 20.1. Western Europe Pediatric Asthma Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Pediatric Asthma Treatment Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pediatric Asthma Treatment Market

• 21.1. UK Pediatric Asthma Treatment Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pediatric Asthma Treatment Market

• 22.1. Germany Pediatric Asthma Treatment Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pediatric Asthma Treatment Market

• 23.1. France Pediatric Asthma Treatment Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pediatric Asthma Treatment Market

• 24.1. Italy Pediatric Asthma Treatment Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pediatric Asthma Treatment Market

• 25.1. Spain Pediatric Asthma Treatment Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pediatric Asthma Treatment Market

• 26.1. Eastern Europe Pediatric Asthma Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Pediatric Asthma Treatment Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pediatric Asthma Treatment Market

• 27.1. Russia Pediatric Asthma Treatment Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pediatric Asthma Treatment Market

• 28.1. North America Pediatric Asthma Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Pediatric Asthma Treatment Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pediatric Asthma Treatment Market

• 29.1. USA Pediatric Asthma Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Pediatric Asthma Treatment Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pediatric Asthma Treatment Market

• 30.1. Canada Pediatric Asthma Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Pediatric Asthma Treatment Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pediatric Asthma Treatment Market

• 31.1. South America Pediatric Asthma Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Pediatric Asthma Treatment Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pediatric Asthma Treatment Market

• 32.1. Brazil Pediatric Asthma Treatment Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pediatric Asthma Treatment Market

• 33.1. Middle East Pediatric Asthma Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Pediatric Asthma Treatment Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pediatric Asthma Treatment Market

• 34.1. Africa Pediatric Asthma Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Pediatric Asthma Treatment Market, Segmentation By Type, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pediatric Asthma Treatment Market Regulatory and Investment Landscape

36. Pediatric Asthma Treatment Market Competitive Landscape And Company Profiles

• 36.1. Pediatric Asthma Treatment Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Pediatric Asthma Treatment Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Pediatric Asthma Treatment Market Company Profiles
  • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Merck And Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

37. Pediatric Asthma Treatment Market Other Major And Innovative Companies

• GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Limited, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Genentech Inc., Chiesi Farmaceutici S.p.A, Dr. Reddy's Laboratories Ltd, Cipla Ltd, Lupin Limited, Zydus Lifesciences Ltd

38. Global Pediatric Asthma Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pediatric Asthma Treatment Market

40. Pediatric Asthma Treatment Market High Potential Countries, Segments and Strategies

• 40.1 Pediatric Asthma Treatment Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Pediatric Asthma Treatment Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Pediatric Asthma Treatment Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer